Q1 2023 Holdings
Filed 2023-05-15 | 35 holdings | $135.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $19.2M | 290,500 | 14.1% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $13.4M | 1,849,402 | 9.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $13.0M | 1,099,309 | 9.6% |
| Cymabay Therapeutics Inc. Common Stock(CBAYUSD) | COM | 23257D103 | $7.7M | 878,500 | 5.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $7.0M | 208,500 | 5.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.0M | 330,000 | 5.1% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $6.9M | 565,257 | 5.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $6.8M | 280,500 | 5.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $5.3M | 23,500 | 3.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.1M | 298,000 | 3.8% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $4.6M | 632,500 | 3.4% |
| Sarepta Tehrapeutics Inc(SRPT) | COM | 803607100 | $4.5M | 32,770 | 3.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.5M | 120,500 | 3.3% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $4.4M | 121,500 | 3.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.3M | 168,000 | 3.1% |
| Iveric BIO IncCall | COM | 99D2WLPZ9 | $3.6M | 1,500 | 2.7% |
| Celldex Therapeutics IncPut | COM NEW | 99D2DH6V9 | $3.6M | 1,000 | 2.7% |
| Argen SE(ARGX) | SPONSORED ADR | 04016X101 | $3.6M | 9,594 | 2.6% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $1.9M | 243,250 | 1.4% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $1.8M | 104,753 | 1.3% |
| Aclaris Therapeutics(ACRS) | COM | 00461U105 | $985.7K | 121,840 | 0.7% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $938.7K | 153,639 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $893.3K | 31,689 | 0.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $892.0K | 303,396 | 0.7% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $736.8K | 154,471 | 0.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $703.1K | 366,204 | 0.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $678.4K | 30,979 | 0.5% |
| Horizon Therapeutics PLC | SHS | G46188101 | $654.8K | 6,000 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $388.1K | 199,031 | 0.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $246.6K | 60,000 | 0.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $233.1K | 14,000 | 0.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $152.7K | 3,575 | 0.1% |
| Hillevax Inc | COM | 43157M102 | $110.2K | 6,664 | 0.1% |
| Kinnate Biopharma Inc | COM | 49705R105 | $31.3K | 5,000 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $10.9K | 90,832 | 0.0% |